371 related articles for article (PubMed ID: 25648594)
21. Specific glycosaminoglycans promote unseeded amyloid formation from beta2-microglobulin under physiological conditions.
Borysik AJ; Morten IJ; Radford SE; Hewitt EW
Kidney Int; 2007 Jul; 72(2):174-81. PubMed ID: 17495865
[TBL] [Abstract][Full Text] [Related]
22. Glycosaminoglycans in extracts of cardiac amyloid fibrils from familial amyloid cardiomyopathy of Danish origin related to variant transthyretin Met 111.
Magnus JH; Stenstad T; Kolset SO; Husby G
Scand J Immunol; 1991 Jul; 34(1):63-9. PubMed ID: 2068532
[TBL] [Abstract][Full Text] [Related]
23. Interaction between glycosaminoglycans and immunoglobulin light chains.
Jiang X; Myatt E; Lykos P; Stevens FJ
Biochemistry; 1997 Oct; 36(43):13187-94. PubMed ID: 9341206
[TBL] [Abstract][Full Text] [Related]
24. Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review.
Ariga T; Miyatake T; Yu RK
J Neurosci Res; 2010 Aug; 88(11):2303-15. PubMed ID: 20623617
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
Pepys MB
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
[TBL] [Abstract][Full Text] [Related]
26. Modulation of Abeta42 fibrillogenesis by glycosaminoglycan structure.
Valle-Delgado JJ; Alfonso-Prieto M; de Groot NS; Ventura S; Samitier J; Rovira C; Fernàndez-Busquets X
FASEB J; 2010 Nov; 24(11):4250-61. PubMed ID: 20585030
[TBL] [Abstract][Full Text] [Related]
27. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
28. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
Huang L; Liu X; Cheng B; Huang K
Arch Biochem Biophys; 2015 Feb; 568():46-55. PubMed ID: 25615529
[TBL] [Abstract][Full Text] [Related]
29. Glycosaminoglycans are part of amyloid fibrils: ultrastructural evidence in avian AA amyloid stained with cuprolinic blue and labeled with immunogold.
Gruys E; Ultee A; Upragarin N
Amyloid; 2006 Mar; 13(1):13-9. PubMed ID: 16690495
[TBL] [Abstract][Full Text] [Related]
30. Cell surface glycosaminoglycans exacerbate plasma membrane perturbation induced by the islet amyloid polypeptide.
Quittot N; Fortier M; Babych M; Nguyen PT; Sebastiao M; Bourgault S
FASEB J; 2021 Feb; 35(2):e21306. PubMed ID: 33475205
[TBL] [Abstract][Full Text] [Related]
31. The potential significance of sulphated glycosaminoglycans as a common constituent of all amyloids: or, perhaps amyloid is not a misnomer.
Kisilevsky R; Snow A
Med Hypotheses; 1988 Aug; 26(4):231-6. PubMed ID: 3050385
[TBL] [Abstract][Full Text] [Related]
32. The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.
McLaughlin RW; De Stigter JK; Sikkink LA; Baden EM; Ramirez-Alvarado M
Protein Sci; 2006 Jul; 15(7):1710-22. PubMed ID: 16751605
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of polyphenols as possible therapeutics for amyloidoses: Comparative analysis of Kaempferol and Catechin.
Bhat WF; Bhat SA; Bano B
Int J Biol Macromol; 2015 Nov; 81():60-8. PubMed ID: 26231329
[TBL] [Abstract][Full Text] [Related]
34. Macromolecular properties of glycosaminoglycans in primary AL amyloid fibril extracts of lymphoid tissue origin.
Stenstad T; Magnus JH; Kolset SO; Cornwell GG; Husby G
Scand J Immunol; 1991 Nov; 34(5):611-7. PubMed ID: 1947796
[TBL] [Abstract][Full Text] [Related]
35. Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts.
Martin EB; Williams A; Heidel E; Macy S; Kennel SJ; Wall JS
Biochem Biophys Res Commun; 2013 Jun; 436(1):85-9. PubMed ID: 23707811
[TBL] [Abstract][Full Text] [Related]
36. Identification of glycosaminoglycans in human renal and splenic secondary AA amyloid fibril preparations.
Stenstad T; Magnus JH; Kolset SO; Husby G
Scand J Rheumatol; 1991; 20(1):1-7. PubMed ID: 2011711
[TBL] [Abstract][Full Text] [Related]
37. Influence of short peptides with aromatic amino acid residues on aggregation properties of serum amyloid A and its fragments.
Skibiszewska S; Żaczek S; Dybala-Defratyka A; Jędrzejewska K; Jankowska E
Arch Biochem Biophys; 2020 Mar; 681():108264. PubMed ID: 31945312
[TBL] [Abstract][Full Text] [Related]
38. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
Chiti F; Dobson CM
Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
[TBL] [Abstract][Full Text] [Related]
39. Topooptical investigations and enzymatic digestions on tissue-isolated amyloid fibrils.
Makovitzky J; Richter S; Appel TR
Acta Histochem; 2006; 108(3):193-6. PubMed ID: 16764914
[TBL] [Abstract][Full Text] [Related]
40. Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro.
Yamaguchi I; Suda H; Tsuzuike N; Seto K; Seki M; Yamaguchi Y; Hasegawa K; Takahashi N; Yamamoto S; Gejyo F; Naiki H
Kidney Int; 2003 Sep; 64(3):1080-8. PubMed ID: 12911560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
